Boehringer tests digital diabetes capabilities; Clinverse doubles headcount after relocating;

> Boehringer Ingelheim is investigating the effect its digital diabetes program has on pharmaceutical costs, clinical care and patient behaviour. Article

> Clinverse has doubled its headcount after relocating to Research Triangle Park. Piece

> CROS NT has signed up to eClinical business Datatrak's Connect Program. Release

> Pi2 Solutions has introduced Drug Safety Triager to streamline screening of drug safety literature. Item

> PMLiVE has updated its pharma social media directory with 40 Twitter accounts. Post